Oryzon Genomics S.A. announced a private placement that it will issue a total of 27,110,751 of the issued and outstanding common shares of the Corporation at an issue price of ?3.68 per share for the gross proceeds of up to ?100,000,000 on June 28, 2024. The transaction has been approved by its Annual General Meeting of Shareholders.